Syndax Pharmaceuticals Statistics
Total Valuation
SNDX has a market cap or net worth of $1.21 billion. The enterprise value is $1.04 billion.
Important Dates
The last earnings date was Monday, August 4, 2025, after market close.
| Earnings Date | Aug 4, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
SNDX has 86.14 million shares outstanding. The number of shares has increased by 10.11% in one year.
| Current Share Class | 86.14M |
| Shares Outstanding | 86.14M |
| Shares Change (YoY) | +10.11% |
| Shares Change (QoQ) | +0.19% |
| Owned by Insiders (%) | 0.66% |
| Owned by Institutions (%) | 109.89% |
| Float | 77.05M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 14.86 |
| Forward PS | 6.54 |
| PB Ratio | 7.35 |
| P/TBV Ratio | 7.36 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 13.29 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.71, with a Debt / Equity ratio of 2.19.
| Current Ratio | 4.71 |
| Quick Ratio | 4.48 |
| Debt / Equity | 2.19 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -16.35 |
Financial Efficiency
Return on equity (ROE) is -113.22% and return on invested capital (ROIC) is -45.16%.
| Return on Equity (ROE) | -113.22% |
| Return on Assets (ROA) | -39.49% |
| Return on Invested Capital (ROIC) | -45.16% |
| Return on Capital Employed (ROCE) | -70.17% |
| Revenue Per Employee | $288,641 |
| Profits Per Employee | -$1.24M |
| Employee Count | 270 |
| Asset Turnover | 0.15 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -32.01% in the last 52 weeks. The beta is 0.73, so SNDX's price volatility has been lower than the market average.
| Beta (5Y) | 0.73 |
| 52-Week Price Change | -32.01% |
| 50-Day Moving Average | 10.30 |
| 200-Day Moving Average | 13.07 |
| Relative Strength Index (RSI) | 74.44 |
| Average Volume (20 Days) | 2,563,465 |
Short Selling Information
The latest short interest is 23.90 million, so 27.75% of the outstanding shares have been sold short.
| Short Interest | 23.90M |
| Short Previous Month | 23.69M |
| Short % of Shares Out | 27.75% |
| Short % of Float | 31.02% |
| Short Ratio (days to cover) | 13.24 |
Income Statement
In the last 12 months, SNDX had revenue of $77.93 million and -$334.99 million in losses. Loss per share was -$3.89.
| Revenue | 77.93M |
| Gross Profit | -185.42M |
| Operating Income | -339.05M |
| Pretax Income | -264.08M |
| Net Income | -334.99M |
| EBITDA | -339.05M |
| EBIT | -339.05M |
| Loss Per Share | -$3.89 |
Full Income StatementBalance Sheet
The company has $468.71 million in cash and $345.52 million in debt, giving a net cash position of $123.18 million or $1.43 per share.
| Cash & Cash Equivalents | 468.71M |
| Total Debt | 345.52M |
| Net Cash | 123.18M |
| Net Cash Per Share | $1.43 |
| Equity (Book Value) | 157.42M |
| Book Value Per Share | 1.83 |
| Working Capital | 418.69M |
Full Balance SheetCash Flow
| Operating Cash Flow | -302.67M |
| Capital Expenditures | n/a |
| Free Cash Flow | -302.67M |
| FCF Per Share | -$3.51 |
Full Cash Flow StatementMargins
| Gross Margin | -237.92% |
| Operating Margin | -435.06% |
| Pretax Margin | -429.84% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
SNDX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -10.11% |
| Shareholder Yield | -10.11% |
| Earnings Yield | -28.91% |
| FCF Yield | -26.12% |
Dividend DetailsAnalyst Forecast
The average price target for SNDX is $36.58, which is 161.29% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $36.58 |
| Price Target Difference | 161.29% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 12 |
| Revenue Growth Forecast (5Y) | 93.93% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SNDX has an Altman Z-Score of -2.3 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -2.3 |
| Piotroski F-Score | 3 |
